PDF herunterladen
Facial Plast Surg 2014; 30(01): 068-071
DOI: 10.1055/s-0033-1363760
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Neurotoxins and Fillers for Skin Rejuvenation

Jessica Mayor
1   Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida
,
Lisa Grunebaum
2   Division of Facial Plastic and Reconstructive Surgery, University of Miami Miller School of Medicine, Miami, Florida
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Januar 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

The ephemeral effects of neurotoxins and fillers are well described for facial remodeling and rejuvenation. Less is known about their long-term effects on skin rejuvenation and neocollagenesis. This article aims to review current available science and literature to support the use of these cosmetic procedures as lasting antiaging treatments.

Keywords

fillers - neurotoxins - rejuvenation - antiaging
 

  • References

  • 1 Reath D. ASPS annual statistics: plastic surgery in 2012. American Society of Plastic Surgeons. February 19, 2013.
    PubMedGoogle Scholar
  • 2 Bowler PJ. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies. J Cosmet Dermatol 2008; 7 (3) 241-244
    CrossrefPubMedGoogle Scholar
  • 3 Chang SP, Tsai HH, Chen WY, Lee WR, Chen PL, Tsai TH. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. Int J Dermatol 2008; 47 (12) 1287-1294
    CrossrefPubMedGoogle Scholar
  • 4 Kapoor R, Shome D, Jain V, Dikshit R. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?. Dermatol Surg 2010; 36 (Suppl. 04) 2098-2105
    CrossrefPubMedGoogle Scholar
  • 5 Shah AR. Use of intradermal botulinum toxin to reduce sebum production and facial pore size. J Drugs Dermatol 2008; 7 (9) 847-850
    PubMedGoogle Scholar
  • 6 Rose AE, Goldberg DJ. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg 2013; 39 (3 Pt 1) 443-448
    CrossrefPubMedGoogle Scholar
  • 7 Quan T, Wang F, Shao Y , et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Invest Dermatol 2013; 133 (3) 658-667
    CrossrefPubMedGoogle Scholar
  • 8 Wang F, Garza LA, Kang S , et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143 (2) 155-163
    CrossrefPubMedGoogle Scholar
  • 9 Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther 2011; 24 (1) 2-27
    Google Scholar
  • 10 Guaraldi G, Orlando G, De Fazio D , et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther 2005; 10 (6) 753-759
    PubMedGoogle Scholar
  • 11 Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg 2006; 32 (11) 1336-1345
    CrossrefPubMedGoogle Scholar
  • 12 Valantin MA, Aubron-Olivier C, Ghosn J , et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17 (17) 2471-2477
    CrossrefPubMedGoogle Scholar
  • 13 Moyle GJ, Lysakova L, Brown S , et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004; 5 (2) 82-87
    CrossrefPubMedGoogle Scholar
  • 14 Brandt FS, Cazzaniga A, Baumann L , et al. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J 2011; 31 (5) 521-528
    CrossrefPubMedGoogle Scholar
  • 15 Simamora P, Chern W. Poly-L-lactic acid: an overview. J Drugs Dermatol 2006; 5 (5) 436-440
    PubMedGoogle Scholar
  • 16 Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxy acids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27 (9) 1135-1148
    CrossrefPubMedGoogle Scholar
  • 17 Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004; 6 (4) 223-226
    CrossrefPubMedGoogle Scholar
  • 18 Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91 (1) 4-15
    PubMedGoogle Scholar
  • 19 Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007; 33 (Suppl. 02) S144-S151
    CrossrefPubMedGoogle Scholar
  • 20 Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg 2008; 34 (2) 210-215
    CrossrefPubMedGoogle Scholar
  • 21 Carter CA, Jolly DG, Worden Sr CE, Hendren DG, Kane CJ. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003; 74 (3) 244-255
    CrossrefPubMedGoogle Scholar
  • 22 Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg 2002; 31 (3) 281-286
    CrossrefPubMedGoogle Scholar
  • 23 Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007; 31 (3) 309-313
    CrossrefPubMedGoogle Scholar
  • 24 Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg 2007; 9 (3) 174-183
    CrossrefPubMedGoogle Scholar
  • 25 Kim DH, Je YJ, Kim CD , et al. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol 2011; 23 (4) 424-431
    CrossrefPubMedGoogle Scholar
  • 26 Cho JM, Lee YH, Baek RM, Lee SW. Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice. J Plast Reconstr Aesthet Surg 2011; 64 (2) e31-e39
    CrossrefPubMedGoogle Scholar
  • 27 Zhu JT, Xuan M, Zhang YN , et al. The efficacy of autologous platelet-rich plasma combined with erbium fractional laser therapy for facial acne scars or acne. Mol Med Rep 2013; 8 (1) 233-237
    PubMedGoogle Scholar
  • 28 Na JI, Choi JW, Choi HR , et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg 2011; 37 (4) 463-468
    CrossrefPubMedGoogle Scholar
  • 29 Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg 2012; 38 (4) 623-630
    CrossrefPubMedGoogle Scholar
  • 30 Lee JW, Kim BJ, Kim MN, Mun SK. The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split-face trial. Dermatol Surg 2011; 37 (7) 931-938
    CrossrefPubMedGoogle Scholar
  • 31 Rodríguez-Flores J, Palomar-Gallego MA, Enguita-Valls AB, Rodríguez-Peralto JL, Torres J. Influence of platelet-rich plasma on the histologic characteristics of the autologous fat graft to the upper lip of rabbits. Aesthetic Plast Surg 2011; 35 (4) 480-486
    CrossrefPubMedGoogle Scholar
  • 32 Cervelli V, Palla L, Pascali M, De Angelis B, Curcio BC, Gentile P. Autologous platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery. Aesthetic Plast Surg 2009; 33 (5) 716-721
    CrossrefPubMedGoogle Scholar
  • 33 Keyhan SO, Hemmat S, Badri AA, Abdeshahzadeh A, Khiabani K. Use of platelet-rich fibrin and platelet-rich plasma in combination with fat graft: which is more effective during facial lipostructure?. J Oral Maxillofac Surg 2013; 71 (3) 610-621
    CrossrefPubMedGoogle Scholar
  • 34 Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol 2010; 9 (1) 66-71
    CrossrefPubMedGoogle Scholar
  • 35 Redaelli A, Romano D, Marcianó A. Face and neck revitalization with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients. J Drugs Dermatol 2010; 9 (5) 466-472
    PubMedGoogle Scholar
  • 36 Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 2007; 33 (3) 263-268
    CrossrefPubMedGoogle Scholar
  • 37 Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg 1999; 1 (3) 165-170
    CrossrefPubMedGoogle Scholar
  • 38 Smith SR, Munavalli G, Weiss R, Maslowski JM, Hennegan KP, Novak JM. A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles. Dermatol Surg 2012; 38 (7 Pt 2) 1234-1243
    CrossrefPubMedGoogle Scholar
  • 39 Lamme EN, Van Leeuwen RT, Brandsma K, Van Marle J, Middelkoop E. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol 2000; 190 (5) 595-603
    CrossrefPubMedGoogle Scholar
  • 40 Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 2007; 15 (5) 708-717
    CrossrefPubMedGoogle Scholar